Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
about
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchCellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropeModeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based StudySignificance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe.APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study.Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.An evolutionary role for HIV latency in enhancing viral transmission.Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.Viral latency and potential eradication of HIV-1.Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.Cellular reservoirs of HIV-1 and their role in viral persistence.Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation.Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Changes in HIV reservoirs during long-term antiretroviral therapy.HIV-1 latency in actively dividing human T cell lines.Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture.Constraints on the dominant mechanism for HIV viral dynamics in patients on raltegravir.Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.Hitting HIV where it hides.Joint modeling of the clinical progression and of the biomarkers' dynamics using a mechanistic model.Mathematical Models of HIV Latency.Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.
P2860
Q28077662-686D3506-2625-4D6A-8949-90AF4C2398D7Q28474278-CB71ACB1-2950-44E8-9E2A-6A14F3519A71Q33510903-A2201E7F-3017-443A-AB2D-07F705A999ABQ33653518-6CF3E533-0A44-4AF2-9BA3-755A857FC35AQ33798584-B4721CDB-6516-49B8-AD38-7DEF14430B84Q34218827-637B858B-73BD-4392-BDF4-BACAC71A56D5Q34743282-0C9F34F3-6907-427B-B23E-D32AFAB72196Q34749384-B568E54D-0350-47E6-917A-6219B6450BB9Q35729054-5EE03A3A-A748-47DD-A797-9CF076B32DBAQ35807225-66922F6A-67D6-42AA-9B4C-F3C25BF6992FQ35973601-B9B90219-21EE-419F-930A-7F80F39F909AQ36613690-78E3F86C-C500-4431-83BD-EB2F410FF508Q37141704-7CA39631-ED92-4BD4-BCED-2956356B5185Q37196089-4DF69085-99B1-4D20-B432-129D2E6CC156Q37544949-13BF7953-3A18-4299-95AF-EB7BB0F2759FQ37644561-24ABF385-249F-4237-B534-A5A7A74807BCQ38268762-10D3BC65-38E9-44D8-956A-0234E825BA93Q38534476-87371E3C-E507-4FC1-A7F2-C26EC1351EAFQ39521847-B066220F-5DBC-4958-A6FD-E4C4524A5A00Q39758249-7632BEA3-D893-4741-B083-60D35A01D0DBQ41832480-D0582469-C7CE-4D85-9F21-6A128BBE1A34Q41876448-E5D64C3C-B972-466B-935A-6B2925BF0E24Q43058206-A82CEEBC-20EE-446E-B9CD-C615815352AAQ45828084-77FD7660-58CD-4F2E-BAEC-74EDD08DC561Q47574091-09032FC1-C7BE-4331-8B3B-503B62DB183EQ52597179-5850BA56-1600-48B0-B8F8-E0723C58A312
P2860
Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@ast
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@en
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@nl
type
label
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@ast
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@en
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@nl
prefLabel
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@ast
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@en
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@nl
P2860
P356
P1476
Low-level HIV-1 replication an ...... HIV-1 in the setting of HAART.
@en
P2093
Ahmad R Sedaghat
P2860
P2888
P356
10.1186/1471-2334-8-2
P577
2008-01-02T00:00:00Z
P5875
P6179
1043291258